FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296312223> ?p ?o ?g. }

• W4296312223 endingPage "2950" @default.
• W4296312223 startingPage "2941" @default.
• W4296312223 abstract "Abstract Background PD‐1/PD‐L1 tumor immunotherapy shows effective anticancer in treatment of solid tumors, so PEI lipid nanoparticles (PEI‐LNP)/siRNA complex (EPV‐PEI‐LNP‐SiRNA) with the therapeutic function of PD‐L1‐siRNA and EGFR short peptide/PD‐L1 double immune‐enhancing function were constructed for the prevention and treatment of EGFR‐positive lung cancer in this study. Method In this study, PEI lipid nanoparticles (PEI‐LNP)/siRNA complex (EPV‐PEI‐LNP‐siRNA) with the therapeutic function of PD‐L1‐siRNA and EGFR short peptide/PD‐L1 double immune‐enhancing function were constructed for the prevention and treatment of EGFR‐positive lung cancer and functional evaluation was conducted. Results On the basis of the construction of the composite nano‐drug delivery system, the binding capacity, cytotoxicity, apoptosis and uptake capacity of siRNA and EPV‐PEI‐LNP were tested in vitro, and the downregulation effect of PD‐L1 on A549 cancer cells and the cytokine levels of cocultured T cells were tested. Lipid nanoparticles delivered siRNA and EGFR short peptide vaccine to non‐small cell lung cancer (NSCLC), increasing tumor invasion and activation of CD8 + T cells. Combination therapy is superior to single target therapy. Conclusion Our constructed lipid nanoparticles of tumor targeted therapy gene siRNA combination had the ability to target cells in vitro and downregulate the expression of PD‐L1, realizing the tumor‐specific expression of immune‐stimulating cytokines, which is a highly efficient and safe targeted therapy nano‐vaccine." @default.
• W4296312223 created "2022-09-20" @default.
• W4296312223 creator A5004351194 @default.
• W4296312223 creator A5008481572 @default.
• W4296312223 creator A5016752102 @default.
• W4296312223 creator A5016850392 @default.
• W4296312223 creator A5022728536 @default.
• W4296312223 creator A5027488634 @default.
• W4296312223 creator A5042807284 @default.
• W4296312223 date "2022-09-18" @default.
• W4296312223 modified "2023-10-17" @default.
• W4296312223 title "Construction of <scp>PEI‐EGFR‐PD‐L1‐siRNA</scp> dual functional nano‐vaccine and therapeutic efficacy evaluation for lung cancer" @default.
• W4296312223 cites W1486919975 @default.
• W4296312223 cites W1951065813 @default.
• W4296312223 cites W1979146520 @default.
• W4296312223 cites W2039551908 @default.
• W4296312223 cites W2057472478 @default.
• W4296312223 cites W2058494666 @default.
• W4296312223 cites W2070024716 @default.
• W4296312223 cites W2077529463 @default.
• W4296312223 cites W2120813964 @default.
• W4296312223 cites W2131783235 @default.
• W4296312223 cites W2312243875 @default.
• W4296312223 cites W2543988213 @default.
• W4296312223 cites W2555883270 @default.
• W4296312223 cites W2801082810 @default.
• W4296312223 cites W2892164007 @default.
• W4296312223 cites W2909301717 @default.
• W4296312223 cites W3000567428 @default.
• W4296312223 cites W4296312223 @default.
• W4296312223 doi "https://doi.org/10.1111/1759-7714.14618" @default.
• W4296312223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36117149" @default.
• W4296312223 hasPublicationYear "2022" @default.
• W4296312223 type Work @default.
• W4296312223 citedByCount "9" @default.
• W4296312223 countsByYear W42963122232022 @default.
• W4296312223 countsByYear W42963122232023 @default.
• W4296312223 crossrefType "journal-article" @default.
• W4296312223 hasAuthorship W4296312223A5004351194 @default.
• W4296312223 hasAuthorship W4296312223A5008481572 @default.
• W4296312223 hasAuthorship W4296312223A5016752102 @default.
• W4296312223 hasAuthorship W4296312223A5016850392 @default.
• W4296312223 hasAuthorship W4296312223A5022728536 @default.
• W4296312223 hasAuthorship W4296312223A5027488634 @default.
• W4296312223 hasAuthorship W4296312223A5042807284 @default.
• W4296312223 hasBestOaLocation W42963122231 @default.
• W4296312223 hasConcept C104317684 @default.
• W4296312223 hasConcept C109316439 @default.
• W4296312223 hasConcept C121608353 @default.
• W4296312223 hasConcept C126322002 @default.
• W4296312223 hasConcept C127561419 @default.
• W4296312223 hasConcept C143998085 @default.
• W4296312223 hasConcept C167672396 @default.
• W4296312223 hasConcept C202751555 @default.
• W4296312223 hasConcept C203014093 @default.
• W4296312223 hasConcept C2776256026 @default.
• W4296312223 hasConcept C2776999253 @default.
• W4296312223 hasConcept C2777701055 @default.
• W4296312223 hasConcept C502942594 @default.
• W4296312223 hasConcept C55493867 @default.
• W4296312223 hasConcept C71924100 @default.
• W4296312223 hasConcept C86803240 @default.
• W4296312223 hasConcept C8891405 @default.
• W4296312223 hasConcept C98274493 @default.
• W4296312223 hasConceptScore W4296312223C104317684 @default.
• W4296312223 hasConceptScore W4296312223C109316439 @default.
• W4296312223 hasConceptScore W4296312223C121608353 @default.
• W4296312223 hasConceptScore W4296312223C126322002 @default.
• W4296312223 hasConceptScore W4296312223C127561419 @default.
• W4296312223 hasConceptScore W4296312223C143998085 @default.
• W4296312223 hasConceptScore W4296312223C167672396 @default.
• W4296312223 hasConceptScore W4296312223C202751555 @default.
• W4296312223 hasConceptScore W4296312223C203014093 @default.
• W4296312223 hasConceptScore W4296312223C2776256026 @default.
• W4296312223 hasConceptScore W4296312223C2776999253 @default.
• W4296312223 hasConceptScore W4296312223C2777701055 @default.
• W4296312223 hasConceptScore W4296312223C502942594 @default.
• W4296312223 hasConceptScore W4296312223C55493867 @default.
• W4296312223 hasConceptScore W4296312223C71924100 @default.
• W4296312223 hasConceptScore W4296312223C86803240 @default.
• W4296312223 hasConceptScore W4296312223C8891405 @default.
• W4296312223 hasConceptScore W4296312223C98274493 @default.
• W4296312223 hasFunder F4320321001 @default.
• W4296312223 hasIssue "21" @default.
• W4296312223 hasLocation W42963122231 @default.
• W4296312223 hasLocation W42963122232 @default.
• W4296312223 hasLocation W42963122233 @default.
• W4296312223 hasLocation W42963122234 @default.
• W4296312223 hasOpenAccess W4296312223 @default.
• W4296312223 hasPrimaryLocation W42963122231 @default.
• W4296312223 hasRelatedWork W1967103478 @default.
• W4296312223 hasRelatedWork W1996150995 @default.
• W4296312223 hasRelatedWork W2032912323 @default.
• W4296312223 hasRelatedWork W2372561159 @default.
• W4296312223 hasRelatedWork W2375344515 @default.
• W4296312223 hasRelatedWork W2390152934 @default.
• W4296312223 hasRelatedWork W2883971212 @default.
• W4296312223 hasRelatedWork W3167775801 @default.

• next